Ingraalys
Montpellier
About Ingraalys
Ingraalys studies genomic and cellular plasticity during development and aging. Exploring the limitations of this plasticity prompted her to investigate the potential reversibility of cellular aging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $326.4K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2024)
- Phone: 0467645780
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/ingraalys-206102 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.